93344-0
Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal
Active
Term Description
The therapy to which the genetic variant identified confers resistance.
LOINC Names Get Info
- Fully-Specified Name
- Treatment to which genetic variant confers resistance:
Prid: Pt: Bld/Tiss: Nom: - Long Common Name
- Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal
- Short Name
- Variant assoc therapy resist
- Display Name
- Treatment to which genetic variant confers resistance Nom (Bld/Tiss)
- Consumer Name Alpha Get Info
- Treatment to which genetic variant confers resistance, Blood or tissue specimen
Part Model Get Info
- Component
- Treatment to which genetic variant confers resistance
LP411094-8
- Analyte
- Treatment to which genetic variant confers resistance
LP411094-8
- Component Numerator
- Treatment to which genetic variant confers resistance
LP411094-8
- Component Numerator Core
- Treatment to which genetic variant confers resistance
LP411094-8
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Prid
LP6850-4
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Bld/Tiss
LP7061-7
- System Core
- Bld/Tiss
LP7061-7
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- NULL
Example Answer List: LL5374-5
Source: Quest Diagnostics Inc.| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Binimetinib | LA30251-5 | ||
| Imatinib | LA30253-1 | ||
| Sunitinib | LA30250-7 | ||
| Trametinib | LA30252-3 | ||
| Midostaurin | LA30247-3 | ||
| Sorafenib | LA30248-1 | ||
| Ponatinib | LA30249-9 |
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.67
- Last Updated
- Version 2.67 (ADD)
- Order vs. Observation
- Observation
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Léčba vůči níž genetická varianta působí rezistenci: |
| el-GR | Greek (Greece) | Θεραπεία στην οποία η γενετική παραλλαγή προσδίδει ανθεκτικότητα: Synonyms: MOLPATH Nom Prid Pt Αίμα Αίμα/Ιστός Θεραπεία στην οποία η γενετική παραλλαγή προσδίδει ανθεκτικότητα Ιστός |
| es-ES | Spanish (Spain) | Tratamiento al que la variante genética confiere resistencia: |
| es-MX | Spanish (Mexico) | Tratamiento al que la variante genética confiere resistencia: |
| fr-FR | French (France) | Traitement pour variant génétique provoquant une résistance: |
| it-IT | Italian (Italy) | Trattamento a cui la variante genetica conferisce resistenza: Synonyms: Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
| zh-CN | Chinese (China) | 因为遗传变异而导致耐受的治疗: Synonyms: 全血或组织; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://